Sinovet Biopharmaceutical

Sinovet Biopharmaceutical is a leading Chinese animal health company specializing in the research, development, and manufacturing of innovative veterinary vaccines and therapeutics. The company focuses on high-end biological products for both livestock, such as swine and poultry, and the rapidly growing companion animal market. Sinovet utilizes advanced technologies including reverse genetics and high-density cell culture to produce high-efficacy vaccines against major diseases like Classical Swine Fever and Porcine Reproductive and Respiratory Syndrome. Headquartered in Beijing, the firm has secured significant venture capital to expand its pipeline into pet monoclonal antibodies and next-generation recombinant vaccines. Its products are designed to meet international standards, positioning the company as a key player in the global animal health market.